Back to News
Market Impact: 0.22

Pre-Market Most Active for Dec 15, 2025 : HPE, QXO, VICI, SMR, CRBG, CRM

HPEQXOVICISMRCRBGCRMNDAQ
Market Technicals & FlowsCorporate EarningsAnalyst EstimatesAnalyst InsightsCompany FundamentalsInvestor Sentiment & Positioning
Pre-Market Most Active for Dec 15, 2025 :  HPE, QXO, VICI, SMR, CRBG, CRM

The Nasdaq-100 pre-market indicator rose 129.58 points to 25,326.31 on total pre-market volume of about 132.7 million shares, with Hewlett Packard Enterprise, QXO, VICI Properties, NuScale (SMR), Corebridge and Salesforce among the most active names. HPE was $23.93 (+$0.06) on 1.31M shares and has seen three upward EPS revisions for the fiscal quarter ending Apr-2026 (consensus $0.43) and a last sale at 88.6% of its $27 target; Salesforce was $260.96 (-$1.27) on 525k shares despite five upward revisions for Apr-2026 (consensus $2.17). NuScale traded $18.69 (+$0.35) on 725k shares and is trading at roughly 55% of its $34 target, while QXO, VICI and Corebridge are trading higher with Zacks mean recommendations in the “buy” range, reflecting a modestly positive, revision-driven pre-market tone with potential upside where shares sit well below analyst targets.

Analysis

The Nasdaq-100 pre-market indicator rose 129.58 points to 25,326.31 on total pre-market volume of 132,686,335 shares, signalling a modestly constructive open with a sentiment score labeled mildly positive (0.2) and a market impact score of 0.22. Pre-market activity is concentrated in a handful of names: HPE traded 1,312,253 shares at $23.93 (+$0.06), QXO 1,071,375 at $21.50, VICI 766,406 at $28.85, SMR 725,050 at $18.69, CRBG 648,981 at $32.14 and CRM 525,246 at $260.96 (-$1.27). Analyst signal dynamics appear to be driving interest: HPE has had three upward EPS revisions for the fiscal quarter ending Apr-2026 (consensus $0.43) and is trading at 88.63% of a $27 target, while Salesforce has five upward revisions for the same quarter (consensus $2.17) despite a small pre-market decline. Several Zacks mean recommendations are in the “buy” range for QXO, VICI and CRBG, supporting the positive tone. SMR is notable for trading at only 54.97% of a $34 target, indicating a larger implied upside but greater valuation dispersion. Implication and risk: the move is revision-driven and concentrated, so near-term performance will depend on confirmatory volume at the open and any company-specific headlines; names with buy-range recommendations may continue to outperform in the short run, but SMR’s large gap to target reflects higher uncertainty and volatility. Investors should treat these pre-market signals as directional rather than decisive and watch for intraday reversals or confirmation of analyst-led momentum.